Oncology Central

Convection-enhanced delivery for glioblastoma: targeted delivery of antitumor therapeutics

0

Glioblastoma is the most common primary brain tumor in adults and carries a dismal prognosis despite advancements in treatment. Diffuse tumor infiltration precludes curative surgical resection and necessitates advancements in drug delivery mechanisms. Convection-enhanced delivery (CED) enables continuous local drug delivery for a diverse population of antitumor agents. Importantly, CED circumvents therapeutic challenges posed by the blood–brain barrier by facilitating concentrated local therapeutic drug delivery with limited systemic effects.

To view restricted content, please:
Share:

Leave A Comment